Hypertension & Cardiovascular Disease in the Elderly: CGP Certified Geriatric Pharmacist Exam Guide

Understanding Hypertension and Cardiovascular Disease in the Elderly for the CGP Exam

As an expert pharmacy education writer for PharmacyCert.com, I understand the critical importance of mastering geriatric pharmacotherapy. The CGP Certified Geriatric Pharmacist exam demands a deep understanding of unique physiological changes, complex comorbidities, and the nuanced approach required when managing older adults. Among the most prevalent and impactful conditions in this population are hypertension and cardiovascular disease (CVD). This mini-article will equip you with the essential knowledge to excel in this high-yield topic on the CGP exam.

Hypertension, often dubbed the "silent killer," affects a staggering proportion of older adults, with prevalence rates exceeding 70% in those over 65 years. Its long-term sequelae contribute significantly to the burden of cardiovascular disease, leading to conditions like heart failure, myocardial infarction, stroke, kidney disease, and cognitive decline. For a geriatric pharmacist, navigating the complexities of diagnosis, treatment, and monitoring in this vulnerable population is not just a clinical skill, but an ethical imperative. The CGP exam will test your ability to apply evidence-based guidelines while simultaneously individualizing care, a hallmark of excellent geriatric pharmacy practice.

Key Concepts: Navigating the Geriatric Cardiovascular Landscape

Epidemiology and Pathophysiology of Hypertension in Aging

The prevalence of hypertension dramatically increases with age. This is largely attributable to age-related vascular stiffening, particularly of the large arteries, leading to isolated systolic hypertension (ISH). ISH, characterized by an elevated systolic blood pressure (SBP) with a normal diastolic blood pressure (DBP), is the most common form of hypertension in older adults and a significant independent risk factor for cardiovascular events. Other physiological changes include reduced baroreflex sensitivity, impaired renal sodium excretion, and increased sympathetic nervous system activity, all contributing to elevated blood pressure.

Diagnosis and Assessment: Beyond the Cuff

Diagnosing hypertension in the elderly requires careful consideration. "White coat" hypertension is more common, necessitating ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) for accurate diagnosis. Crucially, orthostatic hypotension (OH), a significant drop in BP upon standing, is prevalent and can be exacerbated by antihypertensive medications. Assessment for OH should be routine, as it increases the risk of falls, syncope, and adverse cardiovascular outcomes. Atypical presentations of CVD, such as "silent" myocardial infarctions or subtle signs of heart failure, also demand a high index of suspicion.

Individualized Treatment Goals: More Than Just Numbers

Unlike younger adults, blood pressure targets in the elderly are highly individualized. While the ACC/AHA 2017 guidelines recommend a target of <130/80 mmHg for many adults, including older adults who are otherwise healthy and non-frail, this goal must be tempered by factors such as frailty, comorbidity burden, life expectancy, and patient preference. For very frail individuals or those with significant comorbidities, a more relaxed target (e.g., SBP <140-150 mmHg) may be appropriate to prevent overtreatment, orthostatic hypotension, and other adverse events. The CGP exam often presents scenarios where you must discern the most appropriate, safe, and effective BP goal for a specific geriatric patient.

Pharmacological Management: A Careful Balancing Act

Selecting antihypertensive agents in the elderly requires an understanding of age-related pharmacokinetic and pharmacodynamic changes, potential drug-drug interactions (DDIs), and common adverse effects. First-line agents generally include:

• Thiazide-type diuretics (e.g., hydrochlorothiazide, chlorthalidone): Effective, especially for ISH. Watch for electrolyte imbalances (hyponatremia, hypokalemia) and potential for exacerbating gout or hyperglycemia. Chlorthalidone may be preferred due to longer half-life.
• ACE inhibitors (ACEIs) / Angiotensin Receptor Blockers (ARBs): Renoprotective, useful in heart failure and diabetes. Monitor renal function and potassium. Risk of cough (ACEIs), angioedema.
• Dihydropyridine Calcium Channel Blockers (CCBs) (e.g., amlodipine, nifedipine ER): Excellent for ISH and often well-tolerated. Watch for peripheral edema.

Other considerations:

• Beta-blockers: Generally not first-line for uncomplicated hypertension in the elderly, but indicated for specific comorbidities like heart failure, post-MI, or atrial fibrillation. May exacerbate bradycardia, fatigue, and mask hypoglycemia.
• Alpha-blockers: Primarily used for benign prostatic hyperplasia (BPH) with coexisting hypertension, but carry a high risk of orthostatic hypotension.
• Loop diuretics: Reserved for patients with significant edema, heart failure, or renal impairment, not typically for uncomplicated hypertension.

Polypharmacy is a major concern. Each new medication adds to the risk of DDIs and adverse effects. A thorough medication review, including an assessment for potentially inappropriate medications (PIMs) using tools like the Beers Criteria, is essential.

Non-Pharmacological Strategies

Lifestyle modifications remain foundational: a low-sodium diet (DASH diet), regular physical activity tailored to ability, weight management, and moderation of alcohol intake. These interventions can significantly impact blood pressure control and overall cardiovascular health, often reducing the need for or dose of medications.

Complications of Uncontrolled Hypertension and CVD

Chronic uncontrolled hypertension accelerates atherosclerosis and directly damages target organs. Geriatric patients are particularly vulnerable to:

• Stroke: Both ischemic and hemorrhagic.
• Myocardial Infarction and Heart Failure: Especially heart failure with preserved ejection fraction (HFpEF), common in the elderly.
• Chronic Kidney Disease: Hypertension is a leading cause.
• Peripheral Artery Disease (PAD): Increased risk of claudication and limb events.
• Cognitive Impairment and Dementia: Hypertension is a significant risk factor for vascular dementia and may contribute to Alzheimer's disease.

How It Appears on the Exam: CGP Scenarios

The CGP exam will challenge your ability to synthesize information and apply it to complex patient cases. Expect scenario-based questions that present an older adult with multiple comorbidities, polypharmacy, and specific geriatric syndromes. Questions might focus on:

• Drug Selection: Choosing the most appropriate antihypertensive agent considering comorbidities, potential DDIs, and patient-specific factors (e.g., a patient with ISH and peripheral edema, or a patient with heart failure and renal insufficiency).
• Treatment Goals: Identifying the most appropriate individualized blood pressure target for a given patient (e.g., a frail 88-year-old vs. a healthy 70-year-old).
• Monitoring and Adverse Effects: Recognizing and managing common adverse effects in the elderly, such as orthostatic hypotension, electrolyte imbalances, or renal dysfunction. You might be asked to identify which medication is causing a particular symptom.
• Drug Interactions: Identifying significant drug-drug or drug-disease interactions (e.g., NSAIDs and ACEIs, alpha-blockers and phosphodiesterase-5 inhibitors).
• Non-Pharmacological Counseling: Recommending appropriate lifestyle modifications.
• Deprescribing: Identifying opportunities to safely reduce or discontinue medications.

For example, a question might present an 85-year-old female with a history of falls, on multiple antihypertensives, and ask you to identify the most likely cause of her recent dizziness or recommend a medication adjustment. The key is to think critically and apply geriatric-specific principles.

Study Tips for Mastering This Topic

1. Focus on Patient Cases: Instead of rote memorization, work through clinical scenarios. Consider how age, frailty, comorbidities, and polypharmacy impact treatment decisions.
2. Understand Physiological Changes: Review the age-related changes in pharmacokinetics (absorption, distribution, metabolism, excretion) and pharmacodynamics. This foundational knowledge is crucial for understanding drug selection and dosing.
3. Master Guidelines with a Geriatric Lens: Be familiar with major hypertension guidelines (e.g., ACC/AHA 2017), but critically analyze how they apply to the elderly, especially regarding individualized BP targets.
4. Create Drug Tables: Systematically review common antihypertensive classes. For each class, note its mechanism of action, first-line indications in the elderly, common adverse effects (especially those relevant to older adults like orthostatic hypotension, peripheral edema, electrolyte imbalances), contraindications, and significant drug interactions.
5. Practice Interpreting Labs: Understand how to monitor renal function (e.g., eGFR, creatinine clearance using Cockcroft-Gault), electrolytes, and other relevant lab parameters, and how to adjust therapy accordingly.
6. Review Beers Criteria: Familiarize yourself with medications to avoid or use with caution in the elderly, particularly those affecting the cardiovascular system or increasing fall risk.
7. Utilize Practice Questions: Apply your knowledge to real-world scenarios. Our CGP Certified Geriatric Pharmacist practice questions and free practice questions are excellent resources to test your understanding of hypertension and CVD in the elderly.

Common Mistakes to Avoid on the CGP Exam

Here are some pitfalls to watch out for when tackling hypertension and CVD questions on the CGP exam:

• Rigidly Applying Adult Guidelines: One of the biggest mistakes is treating an 80-year-old like a 40-year-old. Always consider individualized goals and the potential for harm from aggressive therapy.
• Ignoring Orthostatic Hypotension: Failing to assess for or consider OH as a potential side effect of antihypertensives can lead to falls and serious consequences.
• Overlooking Polypharmacy and DDIs: Not performing a thorough medication reconciliation or anticipating drug interactions is a critical error. Remember the cascade effect of prescribing.
• Underestimating Atypical Presentations: Assuming typical symptoms for conditions like MI or heart failure in the elderly can lead to missed diagnoses.
• Not Considering Frailty: Frail patients have different physiological reserves and are more susceptible to adverse drug events. Their treatment goals and medication choices must reflect this.
• Failing to Monitor Appropriately: Neglecting to order or interpret relevant lab tests (e.g., potassium with diuretics/ACEIs, renal function with many agents) can lead to serious complications.

Quick Review / Summary

Mastering hypertension and cardiovascular disease management in the elderly is fundamental to excelling on the CGP Certified Geriatric Pharmacist exam. Remember these core principles:

1. Individualization is Key: Blood pressure goals and medication choices must be tailored to the patient's overall health, frailty, comorbidities, and preferences.
2. Prioritize Safety: Be vigilant for orthostatic hypotension, falls, and adverse drug reactions, which are more common and impactful in older adults.
3. Manage Polypharmacy: Conduct regular medication reviews, identify PIMs, and simplify regimens whenever possible to reduce complexity and improve adherence.
4. Understand Age-Related Changes: Account for altered pharmacokinetics and pharmacodynamics when selecting and dosing medications.
5. Integrate Non-Pharmacological Strategies: Lifestyle modifications are crucial adjuncts to pharmacotherapy.
6. Stay Current: Be familiar with current guidelines, but apply them judiciously to the geriatric population.

By adopting a patient-centered, safety-conscious approach, you will not only be well-prepared for the CGP exam but also become a more effective and compassionate geriatric pharmacist. For a comprehensive overview of everything you need to know for the exam, refer to our Complete CGP Certified Geriatric Pharmacist Guide.